Stay updated on Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page
- Check6 days agoChange DetectedNew and updated major study data sections have been added, including Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow. The latest version shows Returned: 2025-12-09 and QC review not concluded.SummaryDifference0.7%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRecord History now includes the 'Results Submitted' status and removes the 'No Results Posted' option from the changes list; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page now shows Revision: v3.3.2 and removes Revision: v3.2.0 as part of a UI version update. This change does not affect the study record content.SummaryDifference0.0%

- Check34 days agoChange DetectedRemoved the page-wide notice about government funding delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedThe page's layout and styling were updated, but the study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference8%

Stay in the know with updates to Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.